The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study

The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study

Summary: Background: Bronchiolitis obliterans syndrome (BOS) after allo-HSCT is a devastating complication with limited therapeutic options. We aimed to assess the efficacy and safety of mesenchymal stem cells (MSCs) in BOS after allo-HSCT. Methods: This multicenter prospective cohort study enrolle...

Full description

Bibliographic Details
Main Authors: Shan Chen, Ke Zhao, Ren Lin, Shunqing Wang, Zhiping Fan, Fen Huang, Xiaoyong Chen, Danian Nie, Xin Du, Ziwen Guo, Dongjun Lin, Li Xuan, Na Xu, Jing Sun, Andy Peng Xiang, Qifa Liu
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396419306450

Internet

http://www.sciencedirect.com/science/article/pii/S2352396419306450

Similar Items